Perrigo Follows FTC's Wake With AbbVie Testosterone Suit
Perrigo on Monday joined a string of litigants alleging that AbbVie engaged in "sham" patent infringement litigation to delay generic competition for its AndroGel testosterone treatment....To view the full article, register now.
Already a subscriber? Click here to view full article